Investment
Features
FeesSafety
Academy
More
Pluang+

Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Analyst Insights
18 Sep 2026
Gordon Thompson
View Source
Bullish
Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim has raised its price target for Restaurant Brands International (QSR) to $86 from $85 and reiterated a Buy rating, reflecting confidence in the company's strategic growth. Restaurant Brands International is enhancing shareholder value through a $1 billion share repurchase program and improving its Burger King menu to attract customers and support premium pricing. The stock trades below the new target, suggesting potential upside. The company, with over 33,000 restaurants globally, will report earnings on October 29, 2026.

Restaurant Brands International price target update is the subject, with Pluang market data for context. Of 107 Consumer Cyclical-sector US stocks on Pluang, 55 rose and 49 fell today. Notable movers include XPEV at USD 10.74 (+1.32%), FNKO at USD 5.43 (+1.31%), and GM at USD 85.54 (-1.25%). Data is as of Sep 18, 2026 20:12 WIB.

More News

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
56 minutes ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
1 hour ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
2 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
SpaceX shares rise 8% on strong revenue growth despite $541M loss, with mixed analyst views on future momentum.

SpaceX shares rise 8% on strong revenue growth despite $541M loss, with mixed analyst views on future momentum.

SpaceX's stock climbed 8% recently after reporting a 92% revenue increase to $7.81 billion, driven by Starlink and AI growth, but also posted a $541 million quarterly loss. The company aims for $100 billion annual revenue by year-end and a trillion-d...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App